Researchers discovered that ALPK2, a heart-specific enzyme, may protect against HFpEF by activating TPM1 in heart muscle ...

Disparate pathogenic mechanisms complicate precision-medicine efforts to treat diffuse large B-cell lymphoma (DLBCL), the most common lymphoma diagnosis. Though potentially curable with frontline ...

A new chemical compound has been making a big impression in the fight against cancer in recent years. Now it seems EBC-46, ...

Acrivon Therapeutics, Inc. (ACRV – Research Report) received a Buy rating and price target from Cantor Fitzgerald analyst Li Watsek today.

The data set from the double-blind phase of the RewinD-LB trial presented today at ILBDC is now accessible in the Investor section o the CervoMed website https://www.cervomed.com/.

Tatsuya Yoshida, Mikito Takefuji, and Toyoaki Murohara in the Department of Cardiology, Nagoya University Graduate School of Medicine, identified an enzyme, alpha-kinase 2 (ALPK2) that is specifically ...

In cancer-associated cachexia, elevated TNF-α and IL-6 exacerbate muscle and fat loss by regulating multiple metabolic signaling pathways, which could be ameliorated by Z526's suppression of NF-κB ...

Kinase is responsible for catalyzing the transfer of phosphate groups. GTPase binds to the nucleotide guanosine triphosphate (GTP) and guanosine diphosphate (GDP) in the protein regulation process.

Nicotine is the substance in tobacco that makes smoking addictive. Limited studies suggest it could temporarily improve attention and cognitive (thinking) function. However, there is not enough ...